CONNECT - DISCOVER - SHARE

Blog Posts

slide

PubGene presented patient data integration with Coremine at the BIGMED Workshop June 1st-2nd

PubGene demonstrated how they can integrate anonymized patient data into their medical search and analysis platform Coremine Medical during a workshop of the BIGMED project; one of three large national ICT Lighthouse projects, funded by the Norwegian Research Council. The patient data, coming from the CoMet-study (NCT01516710: “Oslo randomized laparoscopic […]

slide

Coremine Oncology presented at the “Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies” symposium hosted by CCBIO

On June 18th and 19th, researchers from Haukeland University Hospital (HUS) presented how PubGene’s Coremine Oncology helps them evaluate and analyse genomic variants and somatic mutation in their cancer research at the “Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies” symposium hosted by Centre for Cancer Biomarkers (CCBIO) at […]

slide

BIGMED Lighthouse Project Awarded by Research Council of Norway

The vision behind the BIG data MEDical solution (BIGMED) is to lay the foundation for an ICT platform that addresses the analytic bottlenecks for the implementation of precision medicine and paves the way for novel big data analytics. The solutions will provide the patients with an optimized care which takes […]

slide

Design-driven Innovation Program (DIP) Awarded

PubGene has received funding from the Design-driven Innovation Program (DIP), powered by the Norwegian Center of Design and Architecture (DOGA). The object with the program is to involve design expertise from day one of an innovation project. Through this project PubGene want to reach out to new target groups, the […]

slide

Liquid Biopsy – Helse-vest strategic project with AML research group, Haukeland University Hospital, Bergen

PubGene gave a presentation about Coremine Oncology at a project meeting on 29 September, 2016. The aim of this project is to develop methods to utilize DNA sequencing in blood from cancer patients. Monitoring mutations previously detected in the primary tumour can help doctors to collect information about disease progression. […]

slide

Eurostars Project – GlioPhos Awarded

PubGene was granted funding through a Eurostars project to carry out development of a novel diagnostic tool for Glioblastoma patients in collaboration with Erasmus University Hospital (Rotterdam, Netherlands) and Pepscope (Utrecht, Netherlands).  The project will combine Pepscope’s array expertise and Erasmus Medical Center’s mass spectrometry (MS) platform, with PubGene’s data […]

slide

Collaboration with DNV-GL and Ahus Hospital

A pilot project with DNV-GL and Ahus Hospital aims to extract and present information relevant for completing a pre-surgery report. The project will collect and combine information from hospital IT systems like DIPS (EHR) and MetaVision and present this to surgeons. The solution is based on ontologies and text mining […]

slide

Eurostars Project – OneRNA4OvaCure Awarded

OneRNA4OvaCure aims at seizing a major market opportunity by setting up a new rational method using an innovative RNA sequencing platform (OneRNA) to select the most effective treatment for Ovarian Cancer patients, with a strong focus on immunotherapies. OneRNA4OvaCure will deliver an optimized RNA sequencing platform able to identify and […]

slide

Eurostars Project – PCMPS Awarded

PubGene was granted a Eurostars project funding to carry out the development of a Personalized Cancer Medicine Pipeline and Services (PCMPS) in collaboration with BGI-Europe (Copenhagen, Denmark). The PCMPS is designed to be an end-to-end solution with a high level of credibility and integration for Oncologists and tumor boards in […]

slide

Eurostars Project – EffiBody Awarded

In collaboration with ModiQuest (Oss, Netherlands), Erasmus University Hospital (Rotterdam, Netherlands), iBiomics Gmbh (Bestensee, Germany),  PubGene has been awarded a Eurostars project to develop a novel technology for antibody design. The consortium will deliver an innovative platform technology including bioinformatics tools for the selection, characterization and production of monoclonal antibodies […]